Eighteen cadavers from routine autopsy casework were subject to a study of tissue levels of total mercury in brain, thyroid, and kidney samples by atomic absorption. On these same cadavers, all dental amalgam fillings (the most important source of inorganic mercury exposure in the general population, according to the World Health Organization (WHO) were charted. Total mercury levels were significantly higher in subjects with a greater number of occlusal amalgam surfaces (>12) compared with those with fewer occlusal amalgams (0-3) in all types of tissue (all P < or = 0.04). Mercury levels were significantly higher in brain tissues compared with thyroid and kidney tissues in subjects with more than 12 occlusal amalgam fillings (all P < or = 0.01) but not in subjects with 3 or less occlusal amalgams (all P > or = 0.07).
The higher than expected incidence of neutropenia and GI toxicity might be related to the prolonged half-life and accumulation of total and free Pt after daily administrations. Lack of nephrotoxicity and the low urinary excretion support the use of the drug without hydration. The single intermittent schedule has been selected for clinical development.
We
report the synthesis, characterization, and antiproliferative
activity of organo-osmium(II) and organo-ruthenium(II) half-sandwich
complexes [(η6-p-cym)Os(L)Cl]Cl
(1 and 2) and [(η6-p-cym)Ru(L)Cl]Cl (3 and 4), where
L = N-(2-hydroxy)-3-methoxybenzylidenethiosemicarbazide
(L1) or N-(2,3-dihydroxybenzylidene)-3-phenylthiosemicarbazide
(L2), respectively. X-ray crystallography showed that
all four complexes possess half-sandwich pseudo-octahedral “three-legged
piano-stool” structures, with a neutral N,S-chelating thiosemicarbazone
ligand and a terminal chloride occupying three coordination positions.
In methanol, E/Z isomerization of
the coordinated thiosemicarbazone ligand was observed, while in an
aprotic solvent like acetone, partial dissociation of the ligand occurs,
reaching complete displacement in a more coordinating solvent like
DMSO. In general, the complexes exhibited good activity toward A2780
ovarian, A2780Cis cisplatin-resistant ovarian, A549 lung, HCT116 colon,
and PC3 prostate cancer cells. In particular, ruthenium complex 3 does not present cross-resistance with the clinical drug
cisplatin in the A2780 human ovarian cancer cell line. The complexes
were more active than the free thiosemicarbazone ligands, especially
in A549 and HCT116 cells with potency improvements of up to 20-fold
between organic ligand L1 and ruthenium complex 1.
The issue of food contamination by aflatoxins presently constitutes a social emergency, since they represent a severe risk for human and animal health. On the other hand, the use of pesticides has to be contained, since this generates long term residues in food and in the environment. Here we present the synthesis of a series of chelating ligands based on the thiosemicarbazone scaffold, to be evaluated for their antifungal and antiaflatoxigenic effects. Starting from molecules of natural origin of known antifungal properties, we introduced the thio- group and then the corresponding copper complexes were synthesised. Some molecules highlighted aflatoxin inhibition in the range 67–92% at 100 μM. The most active compounds were evaluated for their cytotoxic effects on human cells. While all the copper complexes showed high cytotoxicity in the micromolar range, one of the ligand has no effect on cell proliferation. This hit was chosen for further analysis of mutagenicity and genotoxicity on bacteria, plants and human cells. Analysis of the data underlined the importance of the safety profile evaluation for hit compounds to be developed as crop-protective agents and at the same time that the thiosemicarbazone scaffold represents a good starting point for the development of aflatoxigenic inhibitors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.